These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 604659)

  • 1. Dapsone in wheat flour as a possible method of therapy in leprosy. A laboratory report.
    Naik SS; Pandya SS
    Lepr India; 1977 Oct; 49(4):516-20. PubMed ID: 604659
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapsone levels after oral therapy and weekly oily injections in Ethiopian leprosy patients.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):191-6. PubMed ID: 6684645
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of DDS therapy on the acetylcholine sweat function test in fifty cases of tuberculoid and maculoanesthetic leprosy.
    Yawalkar SJ; Sanjana HB
    Int J Lepr Other Mycobact Dis; 1974; 42(1):55-7. PubMed ID: 4472091
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of paucibacillary leprosy by WHO regimen.
    Dey SK; Chanda M; Chowdhury A; Panja SK
    Indian J Dermatol; 1987 Jan; 32(1):11-3. PubMed ID: 3453349
    [No Abstract]   [Full Text] [Related]  

  • 5. Regularity of dapsone intake by leprosy patients attending urban treatment centre.
    Naik SS; Ganapati R
    Lepr India; 1977 Apr; 49(2):207-15. PubMed ID: 909287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring the regularity of self administration of dapsone by leprosy patients.
    Kumar A; Balakrishnan S
    Lepr India; 1982 Oct; 54(4):664-70. PubMed ID: 7183832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary dapsone-resistant leprosy in San Francisco.
    Gelber RH
    Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy of leprosy in Bhutan.
    Samuel NM; Samuel S
    Indian J Lepr; 1984; 56(3):647-52. PubMed ID: 6549335
    [No Abstract]   [Full Text] [Related]  

  • 10. The future of leprosy in the Dominican Republic: experience with multidrug therapy.
    Martinez Cruz D
    Lepr Rev; 1986; 57 Suppl 3():127-33. PubMed ID: 3573953
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of dapsone in eliminating M. leprae from the skin of lepromatous patients, a study of 609 cases.
    Koticha KK; Sane AB
    Int J Lepr Other Mycobact Dis; 1971; 39(4):829-37. PubMed ID: 4949310
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of Dapsone in chemotherapy of leprosy--a comparison of responses to therapy in two cohorts in 1960s and 1970s.
    Reddy BN; Neelan PN
    Indian J Lepr; 1984; 56(4):912-8. PubMed ID: 6398345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 15. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed duration MDT in paucibacillary leprosy.
    Mathai R; George S; Jacob M
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):237-41. PubMed ID: 2071980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled comparison of therapeutic effects of DDS in combination with daily or once-monthly rifampicin in patients with lepromatous leprosy.
    Ghosh S; McDougall AC; Hazra SK; Yawalkar SJ
    Indian J Dermatol; 1981 Oct; 26(4):1-6. PubMed ID: 6754585
    [No Abstract]   [Full Text] [Related]  

  • 18. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The Malta project (a program for the eradication of leprosy)].
    Freerksen E; Rosenfeld M; Despasquale G; Bonnici E
    Acta Leprol; 1988; 6(5):7-46. PubMed ID: 3078224
    [No Abstract]   [Full Text] [Related]  

  • 20. A controlled trial to compare the therapeutic effects of dapsone in combination with daily or once-monthly rifampin in patients with lepromatous leprosy.
    Opromolla DV; Tonello CJ; McDougall AC; Yawalkar SJ
    Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):393-7. PubMed ID: 7042603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.